Your session is about to expire
← Back to Search
Robotic Surgery
Robotic Surgery for Throat Cancer
N/A
Waitlist Available
Led By Katherine L Fedder, MD
Research Sponsored by Mark J Jameson, MD, PhD
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Adult male or female with a diagnosis of either oropharyngeal or supraglottic squamous cell carcinoma
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 years
Awards & highlights
Study Summary
This trial will help learn if TORS is a good option for treating throat and voice box cancers. TORS is a surgery where a robot is used to remove the cancer through the mouth.
Who is the study for?
This trial is for adults with a diagnosis of oropharyngeal (throat) or supraglottic (voice box) squamous cell carcinoma, which are types of cancer. It's not open to those whose cancer has spread to other parts of the body (metastatic disease).Check my eligibility
What is being tested?
The study is testing the effectiveness and safety of using transoral robotic surgery (TORS), a newer surgical method that uses a robot called da Vinci to remove throat and voice box cancers through the mouth.See study design
What are the potential side effects?
Potential side effects from TORS may include bleeding, infection, pain at the surgery site, difficulty swallowing, changes in speech quality, and general risks associated with anesthesia.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been diagnosed with a type of throat cancer.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Progression-free survival
Secondary outcome measures
Disease specific survival
Other outcome measures
Functional quality of life
Incidence of adverse events
Overall survival
Trial Design
1Treatment groups
Experimental Treatment
Group I: Transoral robotic surgeryExperimental Treatment1 Intervention
Transoral robotic surgery
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Transoral robotic surgery
2017
N/A
~40
Find a Location
Who is running the clinical trial?
Mark J Jameson, MD, PhDLead Sponsor
Katherine L FedderLead Sponsor
Katherine L Fedder, MDPrincipal InvestigatorUniversity of Virginia School of Medicine
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have been diagnosed with a type of throat cancer.My cancer has spread to other parts of my body.
Research Study Groups:
This trial has the following groups:- Group 1: Transoral robotic surgery
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this investigative undertaking recruiting participants presently?
"The research project, which was posted on March 1st 2013 and most recently edited on November 20th 2022, is not presently enrolling volunteers. Nevertheless, there are 2,677 other trials that have open slots for study participants at the present time."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger